ATE342962T1 - Zusammensetzungen und verfahren für verbesserte zellkultur - Google Patents

Zusammensetzungen und verfahren für verbesserte zellkultur

Info

Publication number
ATE342962T1
ATE342962T1 AT00959455T AT00959455T ATE342962T1 AT E342962 T1 ATE342962 T1 AT E342962T1 AT 00959455 T AT00959455 T AT 00959455T AT 00959455 T AT00959455 T AT 00959455T AT E342962 T1 ATE342962 T1 AT E342962T1
Authority
AT
Austria
Prior art keywords
cell culture
methods
compositions
improved cell
igf
Prior art date
Application number
AT00959455T
Other languages
English (en)
Inventor
Arvia E Morris
Pranhitha Reddy
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE342962T1 publication Critical patent/ATE342962T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00959455T 1999-08-25 2000-08-25 Zusammensetzungen und verfahren für verbesserte zellkultur ATE342962T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15064599P 1999-08-25 1999-08-25
US16894899P 1999-12-03 1999-12-03
US17194999P 1999-12-23 1999-12-23

Publications (1)

Publication Number Publication Date
ATE342962T1 true ATE342962T1 (de) 2006-11-15

Family

ID=27387011

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00959455T ATE342962T1 (de) 1999-08-25 2000-08-25 Zusammensetzungen und verfahren für verbesserte zellkultur

Country Status (14)

Country Link
US (3) US6413744B1 (de)
EP (1) EP1210411B1 (de)
JP (1) JP2003507058A (de)
AT (1) ATE342962T1 (de)
AU (1) AU784506B2 (de)
CA (1) CA2383073A1 (de)
CY (1) CY1105772T1 (de)
DE (1) DE60031419T2 (de)
DK (1) DK1210411T3 (de)
ES (1) ES2272318T3 (de)
IL (2) IL148060A0 (de)
NZ (2) NZ529329A (de)
PT (1) PT1210411E (de)
WO (1) WO2001014529A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US7115231B1 (en) 1998-06-09 2006-10-03 Symyx Technologies, Inc. Parallel reactor with knife-edge seal
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
ATE342962T1 (de) * 1999-08-25 2006-11-15 Immunex Corp Zusammensetzungen und verfahren für verbesserte zellkultur
IL136232A0 (en) * 2000-05-18 2001-05-20 Bar Ilan University Res Author Measurements of enzymatic activity in a single, individual cell in population
US6455007B1 (en) 2000-06-13 2002-09-24 Symyx Technologies, Inc. Apparatus and method for testing compositions in contact with a porous medium
US6439036B1 (en) 2000-06-13 2002-08-27 Symyx Technologics, Inc. Method for evaluating a test fluid
US7018589B1 (en) 2000-07-19 2006-03-28 Symyx Technologies, Inc. High pressure parallel reactor
US7091004B1 (en) 2001-06-08 2006-08-15 Immunex Corporation Regulation of translation for recombinant protein production
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
US20050271663A1 (en) * 2001-06-28 2005-12-08 Domantis Limited Compositions and methods for treating inflammatory disorders
ES2344070T3 (es) * 2001-07-04 2010-08-17 Chromagenics B.V. Secuencias de adn con actividad anti-represora.
WO2003035824A1 (en) * 2001-10-25 2003-05-01 Bar-Ilan University Interactive transparent individual cells biochip processor
US20030166147A1 (en) * 2001-12-14 2003-09-04 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
JP2005532057A (ja) 2002-07-09 2005-10-27 バクスター・インターナショナル・インコーポレイテッド 細胞を培養するための動物性タンパク質非含有培地
AU2003290453A1 (en) * 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
IL154677A0 (en) * 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
US7888110B2 (en) * 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
US8597597B2 (en) * 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
EP1654347B1 (de) * 2003-06-26 2014-06-04 Seng Enterprises Limited Verbesserte Materialien zur Konstruktion von Zellchips, Zellchip-Abdeckungen, Zellchip-Hüllen, prozessierte Zellchips und Verwendungen davon
US7982751B2 (en) * 2003-07-11 2011-07-19 The University Of North Carolina Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop
US20050064524A1 (en) * 2003-08-11 2005-03-24 Mordechai Deutsch Population of cells utilizable for substance detection and methods and devices using same
EP1711166A1 (de) * 2004-02-03 2006-10-18 Chemagis Ltd. Stabile amorphe formen von montelukast natrium
US7403647B2 (en) * 2004-09-13 2008-07-22 Seng Enterprises Ltd. Method for identifying an image of a well in an image of a well-bearing component
EP1763665A1 (de) * 2004-07-07 2007-03-21 Seng Enterprises Limited Verfahren und vorrichtung zur identifizierung eines vertiefungsbildes auf einem bild einer komponente mit vertiefungen
WO2006021959A2 (en) * 2004-08-25 2006-03-02 Seng Enterprises Ltd. Method and device for isolating cells
WO2006044594A2 (en) * 2004-10-15 2006-04-27 Monell Chemical Senses Center Methods for culturing mammalian taste cells
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060172382A1 (en) * 2004-11-08 2006-08-03 Chromagenics B.V. Selection of host cells expressing protein at high levels
AU2005300503B2 (en) * 2004-11-08 2010-12-16 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
EP1844068A4 (de) * 2005-01-25 2009-09-30 Apollo Life Sciences Ltd Moleküle und chimere moleküle davon
ES2352344T3 (es) 2005-01-25 2011-02-17 Seng Enterprises Limited Dispositivo de microfluido para estudio de células.
EP1707634A1 (de) * 2005-03-29 2006-10-04 Octapharma AG Verfahren zur Isolierung von rekombinant hergestellten Proteinen
US20060232821A1 (en) * 2005-04-15 2006-10-19 Sridharan Ranganathan Parallel architecture for vector color error diffusion
WO2007002210A2 (en) * 2005-06-20 2007-01-04 Bresagen, Inc. Embryonic stem cell culture compositions and methods of use thereof
EP1739179A1 (de) 2005-06-30 2007-01-03 Octapharma AG Serumfreie stabile Transfektion und Produktion von rekombinanten humanen Proteinen in humanen Zelllinien
DE102005034043B4 (de) * 2005-07-18 2019-12-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
US20070141555A1 (en) * 2005-10-11 2007-06-21 Mordechai Deutsch Current damper for the study of cells
WO2007052245A1 (en) * 2005-11-03 2007-05-10 Seng Enterprises Ltd. Method and device for studying floating, living cells
CA2633306A1 (en) 2006-01-04 2007-07-12 Baxter International Inc. Oligopeptide-free cell culture media
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
US7807109B2 (en) 2007-05-14 2010-10-05 Freeslate, Inc. Parallel batch reactor with pressure monitoring
US7655191B2 (en) 2007-05-14 2010-02-02 Symyx Solutions, Inc. Methods for chemical reactions in a parallel batch reactor
WO2008149147A2 (en) * 2007-06-06 2008-12-11 Domantis Limited Polypeptides, antibody variable domains and antagonists
MX2009012467A (es) * 2007-06-29 2010-03-30 Hoffmann La Roche Celula de ovario de hamster chino.
MX2010003622A (es) * 2007-10-12 2010-04-14 Hoffmann La Roche Expresion proteinica a partir de acidos nucleicos multiples.
US9975118B2 (en) 2007-11-15 2018-05-22 Seng Enterprises Ltd. Device for the study of living cells
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
US8563303B2 (en) * 2008-03-19 2013-10-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for increasing recloning efficiency
CN102224239A (zh) * 2008-09-26 2011-10-19 先灵公司 高效价抗体生产
US8722615B2 (en) * 2009-12-02 2014-05-13 Acceleron Pharma, Inc. Compositions and methods for increasing serum half-life
HRP20190138T1 (hr) 2011-02-07 2019-03-22 Cerenis Therapeutics Holding Sa Lipoproteinski kompleksi i njihova proizvodnja i uporaba
US8883982B2 (en) 2011-06-08 2014-11-11 Acceleron Pharma, Inc. Compositions and methods for increasing serum half-life
CN104822826B (zh) 2012-10-15 2019-04-30 百时美施贵宝公司 用于蛋白产生的哺乳动物细胞培养过程
WO2015010088A1 (en) * 2013-07-19 2015-01-22 Technical University Of Denmark Methods for modeling chinese hamster ovary (cho) cell metabolism
UY36687A (es) 2015-05-29 2016-11-30 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Anticuerpos contra ox40 y sus usos
CN113493770A (zh) * 2020-03-18 2021-10-12 苏州大学 人源glut5稳定转染细胞株及其在筛选glut5抑制剂中的应用
MX2023006998A (es) 2020-12-22 2023-06-26 Amgen Inc Metodo de cultivo celular.
US20250230215A1 (en) * 2021-11-08 2025-07-17 Memorial Sloan-Kettering Cancer Center Immune cells expressing glucose transporter 5 (glut5) and compositions and methods including the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
WO1991003554A1 (en) * 1989-09-01 1991-03-21 Genentech, Inc. Cells transfected with nucleic acid encoding gtp
US5605690A (en) 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
EP0496453A1 (de) 1991-01-23 1992-07-29 Merck & Co. Inc. Menschlicher glut4 Genpromotor
US5262308A (en) * 1992-01-28 1993-11-16 Thomas Jefferson University Cell lines which constitutively express IGF-1 and IGF-1 R
WO1993020200A1 (en) 1992-04-02 1993-10-14 Imperial Cancer Research Technology Limited Modified cells and method of treatment
US5663314A (en) 1992-11-20 1997-09-02 The Board Of Regents Of The University Of Washington Human signal transduction MAPK kinase
EP0666312A1 (de) 1994-02-08 1995-08-09 Wolfgang A. Renner Verfahren zur Förderung des Wachstums von Säugetierzellen
US5597719A (en) * 1994-07-14 1997-01-28 Onyx Pharmaceuticals, Inc. Interaction of RAF-1 and 14-3-3 proteins
AUPN442295A0 (en) * 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
JP2001518302A (ja) 1997-09-26 2001-10-16 オニックス ファーマシューティカルズ，インコーポレイティド Ｐｋｂキナーゼインヒビターを同定するための組成物及び方法
ATE342962T1 (de) * 1999-08-25 2006-11-15 Immunex Corp Zusammensetzungen und verfahren für verbesserte zellkultur

Also Published As

Publication number Publication date
NZ517215A (en) 2004-01-30
WO2001014529A1 (en) 2001-03-01
ES2272318T3 (es) 2007-05-01
EP1210411A1 (de) 2002-06-05
US20050170462A1 (en) 2005-08-04
NZ529329A (en) 2005-06-24
JP2003507058A (ja) 2003-02-25
DE60031419D1 (de) 2006-11-30
WO2001014529A9 (en) 2002-09-06
IL148060A0 (en) 2002-09-12
DK1210411T3 (da) 2007-02-19
AU7077800A (en) 2001-03-19
CA2383073A1 (en) 2001-03-01
AU784506B2 (en) 2006-04-13
IL148060A (en) 2009-07-20
DE60031419T2 (de) 2007-09-27
US6413744B1 (en) 2002-07-02
US6897040B2 (en) 2005-05-24
CY1105772T1 (el) 2011-02-02
PT1210411E (pt) 2006-12-29
US7166445B2 (en) 2007-01-23
EP1210411B1 (de) 2006-10-18
US20020160455A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
DE60031419D1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
MY148759A (en) Methods to culture circovirus
DE60144145D1 (de) Subtilisin-variante
MY125594A (en) Immortalized cell lines for virus growth
ATE448322T1 (de) Erhöhte in vitro-synthese von aktiven, disulfidbrücken-enthaltenden proteinen
MXPA03005548A (es) Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
SG149061A1 (en) Definitive endoderm
EP1468023A4 (de) Bindungsproteine als biosensoren
SG152273A1 (en) Pdx1 expressing endoderm
ATE405644T1 (de) Verfahren zur herstellung und reinigung von erythropoietin
DE502004008542D1 (de) Verfahren zur reklonierung von produktionszellen
EP1649006A4 (de) Exo-spezifische amylase-polypeptide, diese polypeptide codierende nukleinsäuren und verwendungen davon
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
UA92157C2 (ru) Способ продуцирования гормона роста
IL152406A0 (en) Anti-freeze proteins, their production and use
WO2004011637A3 (en) Modified adamts4 molecules and method of use thereof
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
ES2181897T3 (es) Composicion enzimatica.
ATE398169T1 (de) Verfahren zur reinigung von oozysten mittels enzymatischer verdauung von faeces
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
WO2002068668A3 (en) Compositions and methods for production cell culture
DE60225530D1 (de) Phosphorylierte glyoxalase i und deren verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1210411

Country of ref document: EP

REN Ceased due to non-payment of the annual fee